-
- Benchtop Centrifuges
- Floor-Standing Centrifuges
- Refrigerated Centrifuges
- Mikrozentrifugen
- Mehrzweckzentrifugen
- Hochgeschwindigkeitszentrifugen
- Ultrazentrifugen
- Concentrator
- High-Speed and Ultracentrifugation Consumables
- Zubehör
- Reaktionsgefäße
- Platten
- Gerätemanagement
- Proben- und Informationsmanagement
- IVD Produkte
Read more
Read less
CAR-T Cells: Breakthroughs in Cancer and Auto-Immune Therapies
Mehr erfahren
Weniger lesen
CAR-T Cell Development – The Future of Fighting Cancer
CAR-T cells, genetically engineered and equipped with specific receptors to target and combat cancer cells, are primarily divided into two categories: autologous and allogenic CAR-T cells. Hereby, autologous CAR-T cells derive from the patient’s own white blood cells and are reintroduced after modification, whereas allogenic CAR-T cells are designed as off-the-shelf solutions for use in different patients. However, both approaches have their challenges. The manufacturing process for autologous CAR-T cells is complex and costly, as each patient’s cells must be individually processed. Allogeneic CAR-T cells, on the other hand, currently do not have the same safety profile, necessitating further research to address these issues.